SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?


To: Icebrg who wrote (3394)10/12/2002 2:45:01 PM
From: Qualified Opinion  Read Replies (1) | Respond to of 10345
 
There will probably be an update on the overall ms market.

I don't expect Biogen to add anything new on Antegren.

Rob



To: Icebrg who wrote (3394)10/19/2002 9:05:01 AM
From: Qualified Opinion  Read Replies (2) | Respond to of 10345
 
Ice, there was news.

Per Biogen CC, if interim clinical trial results warrant it, Biogen hopes to make a submission of a NDA for Antegren in early 2004.

Rob